Abstract
Objectives: The objective of the study is to evaluate the expression of CD10 in oral epithelial dysplasia and oral squa-mous cell carcinoma (OSCC) and to determine its role as a potential biomarker in OSCC. Methods: Immunohistochemical evaluation of 40 archival paraffin-embedded tissue specimens grouped into oral epithelial dysplasia and early invasive, well-differentiated, and moderately differentiated OSCC was conducted to determine and compare the CD10 expression among the groups. Stromal positivity of the CD10 expression was calculated and statistically analyzed at p<0.05. Results: The results of the study showed that there was a statistically significant increase in the mean CD10 expression among the four groups. Intergroup comparison showed a statistically significant difference between oral epithelial dysplasia and OSCC while statistical significance was not observed in the various grades of OSCC. Conclusion: CD10 expression could be used as an important biomarker for determining the progression of oral epithelial dysplasia and the overall prognosis of OSCC.
Author supplied keywords
Cite
CITATION STYLE
Patankar, S., Khetan, P., & Sridharan, G. (2022). Immunohistochemical Evaluation of CD10 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: A Cross-sectional Study. Eurasian Journal of Medicine and Oncology, 6(2), 137–141. https://doi.org/10.14744/ejmo.2022.15830
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.